SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laserscope (NASDAQ LSCP) -- Ignore unavailable to you. Want to Upgrade?


To: John Finley who wrote (266)6/11/1999 7:48:00 PM
From: John Finley  Read Replies (1) | Respond to of 314
 
I guess the rumor was correct:


Friday June 11, 8:01 am Eastern Time
Company Press Release
Laserscope Announces the Appointment of Eric Reuter as President and CEO
SAN JOSE, Calif.--(BW HealthWire)--June 11, 1999--The Board of Directors of Laserscope (Nasdaq:LSCP - news) today announced the appointment of Eric Reuter as President and CEO. Mr. Reuter was previously Vice President - Research and Development.

Laserscope designs, manufactures, sells, and services on a worldwide basis an advanced line of medical laser systems and related energy delivery devices for the office, outpatient surgical center, and hospital markets. The Company is a pioneer in the development of lasers and fiber-optic devices for photodynamic therapy to treat cancer and other diseases. More information on Laserscope can be found on the company's Web site at www.laserscope.com or www.photodynamictherapy.com.

Any statements in this announcement about future results are preliminary and based on partial information and assumptions, and actual results may differ. Except for historical information presented, the matters discussed in this announcement contain forward-looking statements that involve risks and uncertainties. These risks and uncertainties are detailed from time to time in the company's public disclosure filings with the U.S. Securities and Exchange Commission (SEC). Copies of Laserscope's most recent forms 10K and 10Q are available upon request from its Investor Relations Department.